Background: Bentiromide is a synthetic peptide composed of benzoic acid, tyrosine, and para-aminobenzoic acid (PABA). It is used as a quantitative measure to evaluate pancreatic exocrine function by assessing the urinary excretion ratio of PABA. The purpose of this study was to quantitatively evaluate pancreatic exocrine function in symptomatic patients with non-metastatic locally advanced pancreatic ductal adenocarcinoma (PDAC) prior to radiotherapy.
No takes yet. Share an insight, caveat, or question.
Hama et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: